Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method of immune cells for specific modification of inflammations

An immune cell, specific technology, applied in genetically modified cells, cells modified by introducing foreign genetic material, blood/immune system cells, etc.

Inactive Publication Date: 2017-03-29
深圳中健生物技术有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The technical problem to be solved by the present invention is to provide a method for preparing immune cells that specifically modifies inflammation, and to solve the problem that the effective long-term suppression and modification of systemic chronic inflammation is still relatively blank in the prior art

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of immune cells for specific modification of inflammations
  • Preparation method of immune cells for specific modification of inflammations
  • Preparation method of immune cells for specific modification of inflammations

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0035] The preparation method of the immune cell specifically modifying inflammation of the present invention comprises the following steps:

[0036] S100, packaging preparation of RET lentivirus: clone the RET gene fragment into a lentiviral expression vector and then package it to obtain a lentivirus containing the RET gene, namely RET-LV;

[0037] S200. Preparation of RET-modified immune cells: Infect and culture the lentivirus containing the RET gene together with human immune cells in a complete medium containing polybrene to obtain RET gene-modified immune cells, namely RET-immune cells .

[0038] The protein encoded by the RET (receptor tyrosine kinase, receptor tyrosine kinase) gene in the above step 100 is a receptor tyrosine kinase. The fragment length of RET gene (NCBI Ref Seq: NM_020975.4) is 3345 base pairs. On July 13, 2016, Veiga-Fernandes stated in the "Nature" that RET protein can regulate the signaling pathway in mucosal inflammation. Mice lacking RET are ...

Embodiment

[0050] The preparation of peripheral blood mononuclear cells (RET-PBMC) specifically modified inflammation comprises the following steps:

[0051] 1. Packaging preparation of lentivirus (RET-LV) containing RET gene

[0052] 1.1 Amplification of RET gene fragment

[0053] The fragment length of the target gene RET (NCBI Ref Seq: NM_020975.4) is 3345 base pairs. Using the cDNA of large intestine epidermal cells containing the RET gene as a template, PCR amplification was carried out with the designed primers RET-F and RET-R. The PCR reaction system is as follows: DNA template 20ng, 100nM RET-F, 100nM RET-R, Taq polymerase 0.5μl, buffer 5μl, 10mM dNTP, double distilled water to 50μl. The PCR reaction conditions are as follows: 5 minutes at 95 degrees, (30 seconds at 94 degrees, 30 seconds at 57 degrees, 45 seconds at 72 degrees), 2-34 cycles, 10 minutes at 72 degrees, and storage at 4 degrees. The primer sequence is:

[0054] RET-F:5'-ATGGCGAAGGCGACGTCCGGT-3'

[0055] RET-R:5...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation method of immune cells for specific modification of inflammations, and belongs to the technical field of bio-pharmacy. The method includes the following steps that S100, RET lentivirus is packaged and prepared, specifically, RET gene segments are cloned to a lentiviral expression vector and then packaged, and lentivirus containing the RET gene is obtained; and S200, RET-modified immune cells are prepared, specifically, the lentivirus containing the RET gene and human body immune cells are subjected to infection cultivation in a complete medium containing polybrene, and the RET-gene-modified immune cells are obtained. The RET gene is used as an antigenic gene relevant to inflammations, the lentivirus is used as a vector for transfection of the immune cells, various immune cells for modifying inflammations are induced and stimulated, and thus specific immunity reactions for inflammation cells are mediated.

Description

technical field [0001] The invention belongs to the technical field of biopharmaceuticals, and more specifically relates to a preparation method of immune cells for specific treatment and modification of chronic inflammation. Background technique [0002] Inflammation is a common physiological response, which refers to an innate immune response stimulated by trauma or pathogen infection. The inflammatory response begins with the release of signal factors from damaged tissue, which stimulates white blood cells, increases the speed of cell division, remodels tissue, and repairs damage. The reaction stops at wound healing, and the internal and external environment of the body reaches a new balance. Normally, an inflammatory response is good for the body, but chronic inflammation is bad for the body. In chronic inflammation, due to the abnormal immune response, the inflammatory response may occur without the body being damaged and not terminated in time. Inflammatory factors ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/867C12N5/10
CPCC12N15/86C07K14/705C12N5/0634C12N5/0636C12N5/0639C12N5/0646C12N9/12C12N2510/00C12N2740/15043C12N2800/107C12Y207/10001
Inventor 肖洪宝
Owner 深圳中健生物技术有限公司